LAST PRICE - AT THE CLOSE
DRUG is DOWN -8% since the begininning of the year
DRUG is UP 3% ABOVE 20 day SMA
DRUG is UP 20% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.00713813
EARNINGS MOMENTUM: YES
1.02% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 58.2% AWAY FROM ALL-TIME HIGHS OF $79.02 |
 |
DRUG IS DOWN -8% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 3013% OVER THE PAST 12 MONTHS |
 |
DRUG IS UP 3% OVER THE PAST 1 MONTH |
 |
2% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 0.03 over the last hour |
 |
DRUG is up 0.8% over the last 5 days |
 |
DRUG is 0.6 above its 8 day SMA |
| $32.13 |  DAY |
$34.88 |
| $31.07 |  PREVIOUS DAY |
$32.56 |
| $30.81 | WEEK |
$37.00 |
| $28.70 | MONTH |
$37.00 |
| $0.93 | YEAR |
$79.02 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
